0001209191-18-028179.txt : 20180504
0001209191-18-028179.hdr.sgml : 20180504
20180504175021
ACCESSION NUMBER: 0001209191-18-028179
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180502
FILED AS OF DATE: 20180504
DATE AS OF CHANGE: 20180504
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SMITH IAN F
CENTRAL INDEX KEY: 0001197032
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31938
FILM NUMBER: 18809164
MAIL ADDRESS:
STREET 1: C/O ACORDA THERAPEUTICS, INC.
STREET 2: 420 SAW MILL RIVER ROAD
CITY: ARDSLEY
STATE: NY
ZIP: 10502
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACORDA THERAPEUTICS INC
CENTRAL INDEX KEY: 0001008848
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 420 SAW MILL RIVER ROAD
CITY: ARDSLEY
STATE: NY
ZIP: 10502
BUSINESS PHONE: 914-347-4300
MAIL ADDRESS:
STREET 1: 420 SAW MILL RIVER ROAD
CITY: ARDSLEY
STATE: NY
ZIP: 10502
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-05-02
0
0001008848
ACORDA THERAPEUTICS INC
ACOR
0001197032
SMITH IAN F
420 SAW MILL RIVER ROAD
ARDSLEY
NY
10502
1
0
0
0
Common Stock
2018-05-02
4
M
0
10000
20.16
A
10000
D
Common Stock
2018-05-02
4
S
0
3677
23.4641
D
6323
D
Common Stock
2018-05-02
4
S
0
6323
23.8648
D
0
D
Non-Employee Stock Option
20.16
2018-05-02
4
M
0
10000
0.00
D
2018-05-21
Common Stock
10000
0
D
Exercise and sales pursuant to a 10b5-1 plan. The exercised options were scheduled to expire in 2018 on the expiration date reported within Table II unless exercised.
The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $22.7750 to $23.7000 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $23.7750 to $24.0500 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
The shares subject to these options vested in installments and were fully vested on 05/21/2009.
/s/ Ian F. Smith
2018-05-04